Methandienone
Dianabol · Dbol · Methandrostenolone · Anabol
Half-life
4 hr
Time to Peak
1 hr
Steady State
~1 days
Dose Range
10–50 mg
Frequency
2x daily
Overview
One of the first commercially available oral AAS. Originally marketed by Ciba as Dianabol. FDA-approved in the 1960s, withdrawn in 1983. 17-alpha-alkylated. Available as oral tablets (primary) and injectable (UGL). The oral form is by far the most common. Aromatizes heavily — significant estrogenic side effects (water retention, gynecomastia). Harm reduction: Hepatotoxic (17-alpha-alkylated). Causes significant water retention and blood pressure elevation. Monitor liver enzymes, blood pressure, and estradiol levels. Typically used in short cycles (4-6 weeks) as a "kickstart" before longer-acting injectables reach stable levels. AI or SERM may be needed for estrogen management.
Mechanism of Action
Testosterone derivative. 17-alpha-alkylated for oral bioavailability. Aromatizes to methylestradiol. Moderate anabolic, moderate androgenic.
Dosing Information
| Route | Dose Range | Half-life | Tmax | Frequency |
|---|---|---|---|---|
| Oral | 10–50 mg | 4 hr | 1 hr | 2x daily, 3x daily |
| Intramuscular (IM) | 10–50 mg | 6 hr | 2 hr | Daily |
Storage & Handling
Room temperature — Available as oral tablets and injectable (UGL). Store at 20-25C. Protect from light.
Used in Regimens
Methandienone is not currently part of any catalog regimen.
Data Sources
- Community Historical Ciba/Dianabol data; Llewellyn's Anabolics
Related Tools
Track Methandienone with Doseline
Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.
Join the waitlistDoseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.